nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—NPY2R—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0306	0.0513	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0296	0.0496	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0211	0.0354	CbGpPWpGaD
Cysteamine—NPY2R—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.0193	0.0323	CbGpPWpGaD
Cysteamine—NPY2R—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.0179	0.0301	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0169	0.0284	CbGpPWpGaD
Cysteamine—NPY2R—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0148	0.0249	CbGpPWpGaD
Cysteamine—Leg pain—Lisinopril—dilated cardiomyopathy	0.0143	0.0353	CcSEcCtD
Cysteamine—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.0136	0.0337	CcSEcCtD
Cysteamine—Appetite absent—Lisinopril—dilated cardiomyopathy	0.0132	0.0328	CcSEcCtD
Cysteamine—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.013	0.0322	CcSEcCtD
Cysteamine—Lethargy—Spironolactone—dilated cardiomyopathy	0.0119	0.0296	CcSEcCtD
Cysteamine—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.0115	0.0284	CcSEcCtD
Cysteamine—Ataxia—Spironolactone—dilated cardiomyopathy	0.011	0.0273	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00946	0.0159	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00946	0.0159	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00907	0.0152	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00907	0.0152	CbGpPWpGaD
Cysteamine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00887	0.022	CcSEcCtD
Cysteamine—SST—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00879	0.0148	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00843	0.0141	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00823	0.0138	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00798	0.0134	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00798	0.0134	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00765	0.0128	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00765	0.0128	CbGpPWpGaD
Cysteamine—Mental disability—Furosemide—dilated cardiomyopathy	0.00761	0.0189	CcSEcCtD
Cysteamine—SST—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00742	0.0124	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00727	0.0122	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00714	0.012	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00711	0.0119	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0071	0.0119	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.00698	0.0117	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00697	0.0117	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.0066	0.0111	CbGpPWpGaD
Cysteamine—Lethargy—Furosemide—dilated cardiomyopathy	0.0065	0.0161	CcSEcCtD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00639	0.0107	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00635	0.0106	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00635	0.0106	CbGpPWpGaD
Cysteamine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00631	0.0156	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00608	0.0102	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00608	0.0102	CbGpPWpGaD
Cysteamine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00593	0.0147	CcSEcCtD
Cysteamine—Dehydration—Furosemide—dilated cardiomyopathy	0.00592	0.0147	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0059	0.00989	CbGpPWpGaD
Cysteamine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0058	0.0144	CcSEcCtD
Cysteamine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00575	0.0142	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00571	0.00958	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—SOD2—dilated cardiomyopathy	0.00568	0.00952	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00566	0.00949	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00548	0.00919	CbGpPWpGaD
Cysteamine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00547	0.0135	CcSEcCtD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00546	0.00916	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00542	0.00908	CbGpPWpGaD
Cysteamine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00539	0.0133	CcSEcCtD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00518	0.00869	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00512	0.00859	CbGpPWpGaD
Cysteamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00511	0.0127	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00501	0.0084	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00497	0.0123	CcSEcCtD
Cysteamine—NPY2R—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00491	0.00823	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00488	0.00818	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00483	0.0081	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00483	0.0081	CbGpPWpGaD
Cysteamine—Renal failure—Furosemide—dilated cardiomyopathy	0.00482	0.0119	CcSEcCtD
Cysteamine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00478	0.0118	CcSEcCtD
Cysteamine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00474	0.0117	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00468	0.00785	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00463	0.00777	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00463	0.00777	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00463	0.00776	CbGpPWpGaD
Cysteamine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00457	0.0113	CcSEcCtD
Cysteamine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00455	0.0113	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00451	0.00756	CbGpPWpGaD
Cysteamine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00449	0.0111	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00449	0.00753	CbGpPWpGaD
Cysteamine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00444	0.011	CcSEcCtD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00444	0.00744	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00435	0.0073	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00435	0.0108	CcSEcCtD
Cysteamine—SST—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00432	0.00724	CbGpPWpGaD
Cysteamine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00432	0.0107	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00431	0.00722	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.0043	0.00722	CbGpPWpGaD
Cysteamine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00424	0.0105	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00417	0.007	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00414	0.00694	CbGpPWpGaD
Cysteamine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00398	0.00985	CcSEcCtD
Cysteamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00394	0.00975	CcSEcCtD
Cysteamine—Erythema—Furosemide—dilated cardiomyopathy	0.00383	0.0095	CcSEcCtD
Cysteamine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00383	0.0095	CcSEcCtD
Cysteamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.0038	0.00942	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00372	0.00623	CbGpPWpGaD
Cysteamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00366	0.00906	CcSEcCtD
Cysteamine—Rash—Spironolactone—dilated cardiomyopathy	0.00363	0.00898	CcSEcCtD
Cysteamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00362	0.00897	CcSEcCtD
Cysteamine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00362	0.00896	CcSEcCtD
Cysteamine—Headache—Spironolactone—dilated cardiomyopathy	0.0036	0.00892	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00356	0.00598	CbGpPWpGaD
Cysteamine—Anaemia—Furosemide—dilated cardiomyopathy	0.00354	0.00878	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00352	0.00591	CbGpPWpGaD
Cysteamine—Agitation—Furosemide—dilated cardiomyopathy	0.00352	0.00873	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00343	0.00576	CbGpPWpGaD
Cysteamine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00343	0.0085	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—TNF—dilated cardiomyopathy	0.00342	0.00574	CbGpPWpGaD
Cysteamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00342	0.00846	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00338	0.00567	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00329	0.00552	CbGpPWpGaD
Cysteamine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00329	0.00814	CcSEcCtD
Cysteamine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00326	0.00808	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00324	0.00803	CcSEcCtD
Cysteamine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00324	0.00802	CcSEcCtD
Cysteamine—Confusional state—Furosemide—dilated cardiomyopathy	0.00316	0.00782	CcSEcCtD
Cysteamine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00313	0.00775	CcSEcCtD
Cysteamine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00307	0.0076	CcSEcCtD
Cysteamine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00304	0.00753	CcSEcCtD
Cysteamine—Anorexia—Furosemide—dilated cardiomyopathy	0.00298	0.00739	CcSEcCtD
Cysteamine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.0029	0.00717	CcSEcCtD
Cysteamine—Erythema—Lisinopril—dilated cardiomyopathy	0.00288	0.00713	CcSEcCtD
Cysteamine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00288	0.00713	CcSEcCtD
Cysteamine—Tension—Lisinopril—dilated cardiomyopathy	0.00282	0.00699	CcSEcCtD
Cysteamine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00279	0.00692	CcSEcCtD
Cysteamine—Somnolence—Furosemide—dilated cardiomyopathy	0.00278	0.00689	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00273	0.00458	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00273	0.00458	CbGpPWpGaD
Cysteamine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00272	0.00674	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00272	0.00456	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0027	0.00669	CcSEcCtD
Cysteamine—Fatigue—Furosemide—dilated cardiomyopathy	0.0027	0.00668	CcSEcCtD
Cysteamine—Tremor—Lisinopril—dilated cardiomyopathy	0.0027	0.00668	CcSEcCtD
Cysteamine—Constipation—Furosemide—dilated cardiomyopathy	0.00268	0.00663	CcSEcCtD
Cysteamine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00266	0.00659	CcSEcCtD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.00265	0.00444	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00262	0.00439	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00262	0.00439	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00261	0.00439	CbGpPWpGaD
Cysteamine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00258	0.00639	CcSEcCtD
Cysteamine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00258	0.00638	CcSEcCtD
Cysteamine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00256	0.00634	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00254	0.00426	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00251	0.0042	CbGpPWpGaD
Cysteamine—Urticaria—Furosemide—dilated cardiomyopathy	0.00249	0.00616	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00248	0.00416	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00248	0.00416	CbGpPWpGaD
Cysteamine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00247	0.00613	CcSEcCtD
Cysteamine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00247	0.00613	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00246	0.00412	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00243	0.00408	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00243	0.00602	CcSEcCtD
Cysteamine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00242	0.00599	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00238	0.00399	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00238	0.00399	CbGpPWpGaD
Cysteamine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00237	0.00586	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00236	0.00395	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00235	0.00582	CcSEcCtD
Cysteamine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00231	0.00571	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00231	0.00387	CbGpPWpGaD
Cysteamine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00228	0.00565	CcSEcCtD
Cysteamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00225	0.00556	CcSEcCtD
Cysteamine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00224	0.00554	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00223	0.00374	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00221	0.00371	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—dilated cardiomyopathy	0.00215	0.00361	CbGpPWpGaD
Cysteamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00214	0.0053	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00214	0.00359	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0021	0.00352	CbGpPWpGaD
Cysteamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00209	0.00517	CcSEcCtD
Cysteamine—Dizziness—Furosemide—dilated cardiomyopathy	0.00207	0.00513	CcSEcCtD
Cysteamine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00207	0.00512	CcSEcCtD
Cysteamine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00204	0.00506	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00203	0.00502	CcSEcCtD
Cysteamine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00202	0.00501	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00201	0.00338	CbGpPWpGaD
Cysteamine—Constipation—Lisinopril—dilated cardiomyopathy	0.00201	0.00497	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00199	0.00334	CbGpPWpGaD
Cysteamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00199	0.00493	CcSEcCtD
Cysteamine—Rash—Furosemide—dilated cardiomyopathy	0.00197	0.00489	CcSEcCtD
Cysteamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00197	0.00488	CcSEcCtD
Cysteamine—Headache—Furosemide—dilated cardiomyopathy	0.00196	0.00486	CcSEcCtD
Cysteamine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00194	0.00479	CcSEcCtD
Cysteamine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00192	0.00476	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00191	0.0032	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00191	0.0032	CbGpPWpGaD
Cysteamine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00187	0.00462	CcSEcCtD
Cysteamine—Nausea—Furosemide—dilated cardiomyopathy	0.00186	0.0046	CcSEcCtD
Cysteamine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00186	0.0046	CcSEcCtD
Cysteamine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00186	0.0046	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00183	0.00307	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00181	0.00303	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00173	0.00291	CbGpPWpGaD
Cysteamine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00173	0.00428	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00171	0.00287	CbGpPWpGaD
Cysteamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00168	0.00417	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00165	0.00277	CbGpPWpGaD
Cysteamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00161	0.00398	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00158	0.00265	CbGpPWpGaD
Cysteamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00155	0.00385	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00155	0.00259	CbGpPWpGaD
Cysteamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00149	0.0037	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00148	0.00249	CbGpPWpGaD
Cysteamine—Rash—Lisinopril—dilated cardiomyopathy	0.00148	0.00367	CcSEcCtD
Cysteamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00148	0.00366	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00148	0.00248	CbGpPWpGaD
Cysteamine—Headache—Lisinopril—dilated cardiomyopathy	0.00147	0.00364	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00146	0.00246	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00146	0.00246	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00142	0.00238	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.0014	0.00236	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.0014	0.00236	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.0014	0.00236	CbGpPWpGaD
Cysteamine—Nausea—Lisinopril—dilated cardiomyopathy	0.00139	0.00345	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00136	0.00228	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00135	0.00226	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00134	0.00225	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00132	0.00221	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00131	0.00219	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00129	0.00216	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00126	0.00212	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00113	0.00189	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00108	0.00181	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00107	0.00179	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00102	0.00172	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000931	0.00156	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000918	0.00154	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000893	0.0015	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00088	0.00148	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00083	0.00139	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000795	0.00133	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGT—dilated cardiomyopathy	0.000793	0.00133	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGT—dilated cardiomyopathy	0.00076	0.00127	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000639	0.00107	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000612	0.00103	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00055	0.000923	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000527	0.000885	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000377	0.000633	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000362	0.000607	CbGpPWpGaD
